709 results found.
2Q14 Revenue: Bacterin
$8.9MM, +8% Estimates 2014 U.S. knee and ankle microfracture procedures of ~410,000; shows promise for distribution channel Claims 6.5% U.S. market share in DBM behind Medtronic, DePuy and Integra ~2/3 of revenue arises from spinal fusion ...
2Q14 Revenue: Symmetry Medical
$101.3MM, +2.3% Instruments $29.8MM, +6% Implants $29.4MM, +5% Cases $17.3MM, +1% Other $4.4MM, +29% Surgical $20.4MM, -9%   Announced proposed sale of OEM Solutions business...
BARE BONES® - July 28, 2014
Medtronic received FDA approval to market the PRESTIGE® LP artificial disc to treat single-level cervical disc disease. Further, the company acquired Visualase, developer of an MRI-gu...
BARE BONES® - June 15, 2014
Medtronic (MDT) entered into a definitive agreement to acquire Covidien (COV) in a cash-and-stock transaction valued at ~US $42.9BB. Upon completion, which is expected in early 2015
BARE BONES® - June 4, 2014
Medtronic is reportedly in early stages of evaluating a bid for Smith & Nephew. (Reuters,
BARE BONES® - June 3, 2014
Humana filed a suit against Medtronic, alleging that fraudulent misrepresentation caused Humana to pay for "ineffective and unsafe use" of Infuse. (
BARE BONES® - May 20, 2014
Medtronic posted fiscal year 2014 (ended 4/25/14) spinal revenue of US $3,041MM, -2% from 2013. (Core Spine $2,570MM, flat; BMP $471MM, -11%) (Growth reflects constant currency.) (
1Q14 Revenue: Medtronic
(fiscal year 2014 ended 4/25/14) $3,041MM, -2% (U.S. $2,103MM, -4%; ex-U.S. $938MM, +4%) Core Spine $2,570MM, flat (U.S. $1,694MM, -2%; ex-U.S. $876MM, +4%) BMP $471MM, -11% (U.S. $409MM, -13%; ex-U.S. $62MM, +5%)  
BARE BONES® - May 6, 2014
Medtronic (MDT) has agreed with certain Plaintiffs' counsel to settle their inventories of filed and unfiled product liability claims related to INFUSE® Bone Graft. Terms indicate that MDT has agreed, subject...
BARE BONES® - April 30, 2014
Medtronic (MDT) denied allegations that it owes US $15MM to Pabban Development from a transaction to acquire its spinal cement device, and claimed that Pabban owes $33MM to MDT for fra...
4Q13/2013 Revenue: Bacterin
4Q13 tissue revenue: $8.3MM, +2% 2013 tissue revenue: $33.1MM, flat Business model going forward: direct sales to orthopaedics and neurosurgery via hybrid model; exploring private label relationships Increased productivity: 25 sal...
BARE BONES® - February 18, 2014
Medtronic reported 3Q14 (ended 1/24/14) spinal revenue of US $744MM, flat vs. 3Q13. (Core Spinal $631MM, flat; Biologics $113MM, -1%) (
4Q13/2013 Revenue: Medtronic
Fiscal 3Q14 ended 1/24/14: $744MM, flat (U.S. $517MM, -1%; ex-U.S. $227MM, +2%) Core Spinal $631MM, flat (U.S. $419MM, -0.7%; ex-U.S. $212MM, +2%) Biologics $113MM, -1% (U.S. $98MM, -2%; ex-U.S. $15MM, +7%)   E...
2013: Who, What, Where and When in an Orthopaedic Year
Before we dive into 2014, let’s review what 2013 wrought. We’ve collected the start-ups, expansions and closures, mergers and acquisitions, fundings, first 510(k)s and products launched across the orthopaedic universe in the preceding 12 months. (Please note, start-ups, first 510(k...
BARE BONES® - December 6, 2013
Seven-year clinical and radiographic outcomes of artificial disc replacement with Medtronic's PRESTIGE® Cervical Disc vs. anterior cervical discectomy and fusion revealed 72.6% overall patient success...
BARE BONES® - November 19, 2013
For FY2Q14 (ended 10/25/13), Medtronic reported spinal revenue of US $746MM, -3% from 2Q13. (U.S. $517MM, -6%; ex-U.S. $229MM, +2%) (Core Spinal $636MM, -1%; BMP $110M...
3Q13 Revenue: Medtronic
(for FY2Q14 ended 10/25/13) $746MM, -3% (U.S. $517MM, -6%; ex-U.S. $229MM, +2%) Core Spinal $636MM, -1% (U.S. $421MM, -2%; ex-U.S. $215MM, +2%) BMP $110MM, -17% (U.S. $96MM, -19%; ex-U.S. $14MM, flat)   ...
3Q13 Revenue: RTI Surgical
Orthopaedic-related tissue distribution revenue $41.5MM, +39% (Pioneer Surgical/PST $16.1MM) Spine $17.6MM, +73% (Legacy RTI spine +5%) Bone Graft Substitutes/General Orthopaedic (BGS/GO) $7.6MM, -3% Sports Medicine $9.5MM, -19% ...
BARE BONES® - October 21, 2013
Medtronic (MDT) launched OLIF51™ (Oblique Lateral Interbody Fusion), reportedly the 1st procedure to enable reproducible lateral access to the L5-S1 disc space. The procedure eliminates ...
BARE BONES® - October 16, 2013
RTI Surgical (RTIX) reported preliminary 3Q13 revenue of ~US $54.7MM, compared to prior guidance of $59MM to $61MM. Further, RTIX entered into a new agreement with Medtronic Sofamor Danek to process al...
Web Exclusive: Highlights from THE SPINE MARKET report
In 2012, revenues generated by global sales of spinal implants and instrumentation reached an estimated $7.35 billion. Though historic double-digit growth in the segment flattened in 2010, looking ahead, conservative increases should occur based upon a shift in focus to more cervical discs, la...
BARE BONES® - October 3, 2013
Medtronic announced CE Mark approval and European launch of the Compact CORNERSTONE-SR® Alliance™ cage. Features include 4 titanium fixation spikes, bevelled edge and
BARE BONES® - October 1, 2013
MiMedx entered into a distribution agreement with Medtronic and its SpinalGraft Technologies subsidiary to provide privately-labeled PURION® processed allograft, to be market...
BARE BONES® - August 20, 2013
Medtronic posted FY1Q14 (ended 7/26/13) spinal revenue of US $765MM, -1% from 1Q13. (Core Spinal $641MM, +1%, BMP $124MM, -11%) Growth reflects constant currency. (
2Q13 Revenue: Medtronic
(for FY1Q14 ended 7/26/13) $765MM, -1% (U.S. $536MM, -4%; ex-U.S. $229MM, +5%) Core Spinal $641MM, +1% (U.S. $426MM, -1%; ex-U.S. $215MM, +4%) BMP $124MM, -11% (U.S. $110MM, -14%; ex-U.S. $14MM, +15%)  
  • 8401 Chagrin Road, Suite 18
  • Chagrin Falls, Ohio 44023 USA
  • Phone: 440.543.2101 • Fax: 440.543.2122
  • ©1992-2019 ORTHOWORLD
  • All Rights Reserved.
  • Site Managed By:
  • Open Professional Group